Skip to content
PeptideRank

Every price, read off the source

What a peptide prescription actually costs, checked line by line.

PeptideRank reads every provider's own pricing page and prints the ongoing rate (not the sign-up rate), the dose that price buys, and whether they name the pharmacy. Plus 31 free dose calculators and a cited research library. Dated, sourced, and the ranking criteria are printed on the page.

providers on our boards
216
prices checked at the source
945
full written reviews
240
cited references
912

Partner offers, by compound

Advertising disclosure — we may earn a commission at no extra cost to you. How we earn

What is on this site

Where to get it

Sermorelin, prescribed properly.

Sermorelin and the GH-secretagogues are not over-the-counter, not safely. We looked at who actually prescribes them, what a compounding pharmacy adds to the price, and which providers hide the real cost until checkout.

118 providers compared

See the ranking

The GLP-1 board

Tirzepatide, ranked on the real monthly cost.

Compounded tirzepatide's advertised price and its true no-commitment monthly cost are not always the same number. We checked every provider's own pricing page, prepay tiers included, before ranking anyone.

175 providers compared

See the ranking

The longevity board

NAD+, sold with no approved drug behind it at all.

FDA has resolved the tirzepatide and semaglutide shortages; restrictions on compounding copies still apply. NAD+ has no FDA-approved drug product. Pharmacy disclosure and price still need checking: 5 of the 125 providers compared do not publish a price before you start an intake.

125 providers compared

See the ranking

How a ranking is decided

Disclosure first, price second.

How we earn

Compounded peptide pricing is quoted to be hard to compare: a “from” figure that only applies at the smallest dose, a first-month rate that is not the ongoing one, a pharmacy nobody will name. Of the 241 providers we have checked so far, just 64 states which pharmacy fills its prescriptions and what that pharmacy's FDA category is. That gap is the ranking.

  1. We read the seller's own pageEvery figure on a board came off that company's public pricing page, on a date printed beside it. Not a press release, not another comparison site, not a number a merchant sent us.
  2. Pharmacy disclosure ranks firstA provider that names the pharmacy filling its prescriptions and states that pharmacy's FDA category outranks one that will not — before price is considered at all.
  3. Then, and only then, priceProviders that tie on disclosure are ordered by their own advertised price, low to high. A “starting at” floor is labeled as a floor, never reprinted as if it were a monthly cost.

Free, and free of a signup

Work out the number before you spend anything.

All 31 calculator pages

The reconstitution calculator

Put in the vial strength and the diluent you were given, put in the dose your prescriber wrote down, and read the syringe. It draws the plunger position rather than printing a decimal for you to squint at. It suggests no dose of anything — every number in it is one you supply.

28 molecules, each with its own FDA-status page

Insulin units, converted honestly

There is no fixed “N units = X mg” — it depends entirely on how your vial was mixed. These pages show the arithmetic worked through on labeled hypothetical concentrations instead of handing you a constant that is wrong for most vials.

The same rosters, cheapest first

If price is the only thing you care about, our ranking is in your way. These views take a board's roster and sort it purely on the verified monthly figure — no editorial order applied at all.

The research desk

912 cited references, open the evidence behind the claims.

All 134 articles

Articles link to the trial reports, reviews and regulatory records behind their claims. They distinguish animal findings from human evidence and discuss limitations such as retracted papers. Open the cited sources to check what was studied and what remains unknown.

How a source qualifies, and what happens when one is retracted, is written down on our editorial policy.

Open the working, not just the answer

The pricing data, published as a table.

Every provider we track, for every compound it sells, sortable and filterable in one page — not a conclusion about the data, the data itself. Cite it, argue with it, or check a single row against the provider's own site: every figure carries the date it was read and the page it came from.

The cross-board pricing index945 priced rows · 216 providers · 10 boardsThe advertised price, whether the pharmacy filling it is named with an FDA category, and the date we read that price off the seller's own page — every board's rows, unmodified, in one sortable table.Open the pricing index

Our editorial bylines

3 editorial bylines organize our pricing, women's health and clinical-evidence coverage. These are publishing identities, not medical credentials. Coverage and contact details are on the team page.

Editorial policyAbout PeptideRankHow we earn

  • Read off the provider's own page

    Every price here was taken from the company's own public pricing page, on a date we print beside it. Never from a press release, a comparison table, or another site.

  • Silence is a finding

    When a provider will not say what a higher dose costs, or will not name the pharmacy that fills it, we print that instead of estimating around it.

  • Straight about the money

    We say plainly how we are funded: some links here are affiliate links, and a commission may follow. The write-up beside a provider is what should decide it, not the payout.